Aspirin for recurrence prevention in bipolar disorder-Promising, yet clinically understudied?

B C M Haarman, M K de Boer, C M van der Gaag, H Burger, W A Nolen, R A Schoevers

Research output: Contribution to journalEditorialAcademicpeer-review

1 Citation (Scopus)
251 Downloads (Pure)


Current available maintenance pharmacotherapy for bipolar disorder (BD) leaves ample room for improvement. Up to 50% of patients with BD do not respond adequately to available treatments and still suffer from manic and/or depressive episodes. In this perspective article, we will give an overview of the neuropharmacodynamics of (low-dose) aspirin, reflect on the published clinical studies and argue that aspirin is a promising, yet understudied option for recurrence prevention This article is protected by copyright. All rights reserved.

Original languageEnglish
Pages (from-to)13-15
Number of pages3
JournalBipolar Disorders
Issue number1
Early online date25-Nov-2018
Publication statusPublished - Feb-2019

Cite this